About Charles Schumacher
Form D filings for Biopharmaceutical Research from 2020 to 2023 list Charles Schumacher as director.
Charles Schumacher first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Charles Schumacher in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Charles Schumacher works with at each company, as listed on that company's latest Form D.
Biopharmaceutical Research Co · Form D, Aug 9, 2023
DW
David Weinmann
Executive officer
GH
George Hodgin
Chief Executive Officer and director
OI
Osagie Imasogie
Director